olaptesed pegol (NOX-A12)

News alerts, weekly reports and conference planners

Company:

TME Pharma

Drug class:

CXCL12 inhibitor

Related drugs:

‹

›

No biomarker	Glioblastoma	No biomarker	Glioblastoma	NOX-A12 Sensitive: B - Late Trials NOX-A12 Sensitive : B	NOX-A12 Sensitive: B - Late Trials NOX-A12 Sensitive : B
MGMT unmethylation	Glioblastoma	MGMT unmethylation	Glioblastoma	NOX-A12 Sensitive: C3 – Early Trials NOX-A12 Sensitive : C3	NOX-A12 Sensitive: C3 – Early Trials NOX-A12 Sensitive : C3
CXCL12 expression	Glioblastoma	CXCL12 expression	Glioblastoma	NOX-A12 Sensitive: C3 – Early Trials NOX-A12 Sensitive : C3	NOX-A12 Sensitive: C3 – Early Trials NOX-A12 Sensitive : C3

Associations
(3)